Table 4

A guide to the optimal clinical use of 99mTc-HMPAO SPECT (% of significant test results4-150 for pairwise disease group comparisons)

Alzheimer’s diseaseVascular dementiaLewy body diseaseFrontotemporal dementia
Vascular dementia60
Lewy body disease1812
Frontotemporal dementia502536
Progressive aphasia27133510 
  • 4-150 Those with likelihood ratios different from 1 with 95% confidence.